MHC class I peptide stability: Implications for immunodominance, in vitro proliferation, and diversity of responding CTL

被引:0
|
作者
Busch, DH
Pamer, EG [1 ]
机构
[1] Yale Univ, Infect Dis Sect, Sch Med, New Haven, CT 06520 USA
[2] Yale Univ, Immunol Sect, Sch Med, New Haven, CT 06520 USA
来源
JOURNAL OF IMMUNOLOGY | 1998年 / 160卷 / 09期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infection of BALB/c mice with Listeria monocytogenes primes CD8(+) cytotoxic T cells specific for four different H2-K(d)-restricted peptides, In vitro restimulation of L. monocytogenes immune splenocytes with each of these peptides resulted in larger T cell responses to p60 217-225 and mpl 84-92 than to LLO 91-99 and p60 449-457, Direct frequency analyses of immune splenocytes, however, revealed that LLO 91-99 and p60 217-225 elicit dominant T cell responses, while p60 449-457 and mpl 84-92 elicit minor, subdominant responses. Restimulation of immune splenocytes with a range of peptide concentrations revealed that T cells with dominant specificities respond optimally to low peptide concentrations, while T cells specific for subdominant epitopes expand maximally to high peptide concentrations. This disparity correlates with the stability of H2-K(d)/epitope complexes: the two dominant epitopes form stable complexes, while the subdominant epitopes form less stable complexes with H2-K(d), Interestingly, T cells specific for LLO 91-99 and p60 217-225 express more complex TCR-V beta repertoires than p60 449-457- and mpl 84-92-specific T cells. Thus, in our system, dominant T cell responses have relatively diverse TCR repertoires and are specific for peptides that form stable complexes with MHC class I molecules. Determining the precise roles of epitope/MHC class I stability and TCR repertoire in the generation of dominant T cell responses will require further investigation.
引用
收藏
页码:4441 / 4448
页数:8
相关论文
共 50 条
  • [21] MHC class I antigen processing of Listeria monocytogenes proteins: implications for dominant and subdominant CTL responses
    Pamer, EG
    Sijts, AJAM
    Villanueva, MS
    Busch, DH
    Vijh, S
    IMMUNOLOGICAL REVIEWS, 1997, 158 : 129 - 136
  • [22] Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability
    vanderBurg, SH
    Visseren, MJW
    Brandt, RMP
    Kast, WM
    Melief, CJM
    JOURNAL OF IMMUNOLOGY, 1996, 156 (09): : 3308 - 3314
  • [23] Deletion of naive T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance
    Hess, Sabrina M.
    Young, Ellen F.
    Miller, Keith R.
    Vincent, Benjamin G.
    Buntzman, Adam S.
    Collins, Edward J.
    Frelinger, Jeffrey A.
    Hess, Paul R.
    TRANSPLANT IMMUNOLOGY, 2013, 29 (1-4) : 138 - 145
  • [24] MHC class I peptide binding and tapasin
    Vilches, C
    JOURNAL OF IMMUNOLOGY, 2003, 171 (01): : 3 - 3
  • [25] Peptide presentation by MHC class I molecules
    Williams, DB
    Vassilakos, A
    Suh, WK
    TRENDS IN CELL BIOLOGY, 1996, 6 (07) : 267 - 273
  • [26] MHC class I diversity in chimpanzees and bonobos
    Vincent Maibach
    Jörg B. Hans
    Christina Hvilsom
    Tomas Marques-Bonet
    Linda Vigilant
    Immunogenetics, 2017, 69 : 661 - 676
  • [27] MHC class I diversity in chimpanzees and bonobos
    Maibach, Vincent
    Hans, Joerg B.
    Hvilsom, Christina
    Marques-Bonet, Tomas
    Vigilant, Linda
    IMMUNOGENETICS, 2017, 69 (10) : 661 - 676
  • [28] RECOGNITION OF MHC CLASS-I ALLODETERMINANTS REGULATES THE GENERATION OF MHC CLASS-II-SPECIFIC CTL
    MCCARTHY, SA
    SINGER, A
    JOURNAL OF IMMUNOLOGY, 1986, 137 (10): : 3087 - 3092
  • [29] CTL TARGETING OF TUMORS WITH DEFECTS IN MHC CLASS I ANTIGEN PROCESSING
    Wolpert, Elisabeth Z.
    van Hall, Thorbald
    Grufman, Per
    van der Veer, Michael
    Laban, Sandra
    Fredriksson, Vanoohi
    Camps, Marcel
    Torstensson, Elisabeth
    Ossendorp, Ferry
    Ljunggren, Hans-Gustaf
    Kaerrel, Klas
    Melief, Cornelis J. M.
    Offringa, Rienk
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3672 - 3672
  • [30] IN-VIVO CTL INDUCTION WITH POINT-SUBSTITUTED OVALBUMIN PEPTIDES - IMMUNOGENICITY CORRELATES WITH PEPTIDE-INDUCED MHC CLASS-I STABILITY
    LIPFORD, GB
    BAUER, S
    WAGNER, H
    HEEG, K
    VACCINE, 1995, 13 (03) : 313 - 320